Article Details
Retrieved on: 2022-08-04 16:51:48
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Phase 1 study demonstrates protective efficacy of next-generation antimalarial monoclonal antibody without evident safety concerns.
Article found on: consumer.healthday.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here